364P Tepotinib with an EGFR-tyrosine kinase inhibitor (TKI) in patients with EGFR-mutant MET-amplified NSCLC: A case series
作者
A.R. Ahmad,Lye Mun Tho,Y.K.J. Chik,W.C.K. Lee,T-Y. Yang,Xiuning Le,Anna Eisert,U. Himpe,Charlotte De Bondt,Julien Mazières,I. Petrini,W-S. Lam,K. Joshi,K. Berghoff,Soetkin Vlassak,Niki Karachaliou,Anthonie J. van der Wekken,T-C. Hsia
出处
期刊:Annals of Oncology [Elsevier BV] 日期:2022-11-01卷期号:33: S1584-S1584被引量:2